EUVIMEDEUVIMED entdecken
CrossrefInfokarte

High‐power Magnetotherapy: A New Weapon in Urinary Incontinence?

Maria VADALÀ, Beniamino PALMIERI, Andrea MALAGOLI, Carmen LAURINO

LUTS: Lower Urinary Tract Symptoms · 2018-09 · 10 (3) · 266-270

DOI: 10.1111/luts.12174 ↗
AbstractBibliografische Angaben

Abstract

Objective Urinary incontinence ( UI ) is one of the most common urinary system diseases that mostly affects women but also men. We evaluated the therapeutic efficacy of functional magnetic stimulation ( FMS ) as potential UI treatment with improvements in the pelvic floor musculature, urodynamic tests and quality of life. Methods A total of 20 UI patients (10 females and 10 men, mean age 64, 14 years), including 10 with stress UI , four with urgency UI and six with mixed UI , were treated with FMS (20 min/session) twice a week for 3 weeks. The patients' impressions, records in urinary diaries, and scores of three life stress questionnaires (overactive bladder symptom questionnaire [ OAB ‐q], urogenital distress inventory questionnaire‐short form [ UDI ‐6], incontinence impact questionnaire‐short form [ IIQ ‐7]) were performed pre‐ and post‐treatment. Results Significant reductions ( P < 0.01) of micturition number and nocturia after magnetic treatment were evidenced. The urodynamic tests recorded a significant increase in cystometric capacity (147 ± 51.3%), in maximum urethral closure pressure (110 ± 34%), in urethral functional length (99.8 ± 51.8%), and in pressure transmission ratio (147 ± 51.3%) values compared with the baseline values. Conclusions These preliminary findings suggest that FMS with M agneto STYM (twice weekly for 3 weeks) improves the UI and may be an effective treatment for this urogenital disease.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →